Author

Josh C. Woloszynek

Observed names: Josh C. WOLOSZYNEK, Josh Woloszynek

Institution: BioMarin (United States)

Observed institutions: Emory University, Washington University in St. Louis, BioMarin (United States)

OpenAlex ID: A5017164996

Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB

2014 · Shih-hsin Kan, Mika Aoyagi-Scharber, et al. · Proceedings of the National Academy of Sciences · 111

Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target

2019 · Yedda Li, Yue Xu, et al. · Proceedings of the National Academy of Sciences · 95

Lysosomal Dysfunction Results in Altered Energy Balance

2007 · Josh C. Woloszynek, Trey Coleman, et al. · Journal of Biological Chemistry · 71

Metabolic Adaptations to Interrupted Glycosaminoglycan Recycling

2009 · Josh C. Woloszynek, Atilla Kovacs, et al. · Journal of Biological Chemistry · 42

Cathepsin G-regulated Release of Formyl Peptide Receptor Agonists Modulate Neutrophil Effector Functions

2012 · Josh C. Woloszynek, Ying Hu, et al. · Journal of Biological Chemistry · 28

Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor

2021 · Michael C. Babcock, Christina R. Mikulka, et al. · Scientific Reports · 21

Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII

2004 · Josh C. WOLOSZYNEK, Marie ROBERTS, et al. · Biochemical Journal · 20

Deletion of Epstein-Barr Virus Regulatory Sequences Upstream of the EBNA Gene Promoter Wp1 Is Unfavorable for B-Cell Immortalization

2002 · Lina I. Yoo, Josh Woloszynek, et al. · Journal of Virology · 10

Engineering of a recombinant NAGLU fusion protein with insulin-like growth factor 2 leads to improved cellular uptake via a glycosylation-independent lysosomal targeting pathway

2014 · Mika Aoyagi-Scharber, Terri Christianson, et al. · Molecular Genetics and Metabolism · 4

Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular Dystrophy

2025 · Todd Oppeneer, Yulan Qi, et al. · Nucleic Acid Therapeutics · 3

Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction

2022 · Jenna Magat, Samantha Jones, et al. · Journal of Biological Chemistry · 2

120. Metabolic and clinical adaptations to interrupted lysosomal recycling

2009 · Mark Sands, Josh Woloszynek, et al. · Molecular Genetics and Metabolism

Works count: 12

Citation count: 407

H-index: 8

I10-index: 8